ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 229 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 1.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $674,000 | -19.2% | 10,159 | -6.5% | 0.00% | 0.0% |
| Q4 2020 | $834,000 | +73.8% | 10,862 | -2.6% | 0.00% | +100.0% |
| Q3 2020 | $480,000 | -0.4% | 11,149 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $482,000 | -64.1% | 11,149 | -76.1% | 0.00% | -66.7% |
| Q1 2020 | $1,342,000 | +89.3% | 46,670 | +317.6% | 0.01% | +200.0% |
| Q4 2019 | $709,000 | +123.7% | 11,176 | -0.6% | 0.00% | +100.0% |
| Q3 2019 | $317,000 | -89.3% | 11,247 | -89.9% | 0.00% | -90.0% |
| Q2 2019 | $2,958,000 | +43.0% | 111,622 | -1.0% | 0.01% | +25.0% |
| Q1 2019 | $2,068,000 | +45.9% | 112,723 | -1.3% | 0.01% | +33.3% |
| Q4 2018 | $1,417,000 | -7.6% | 114,160 | +42.7% | 0.01% | 0.0% |
| Q3 2018 | $1,534,000 | +41.0% | 80,000 | 0.0% | 0.01% | +50.0% |
| Q2 2018 | $1,088,000 | – | 80,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |